TSHR

TSHR 분자 정보

영어 이름Thyroid stimulating hormone receptor시판 약물 수3
임상 약물 수6표적 별명TSHR,Thyroid Stimulating Hormone Receptor,LGR3,Thyroid-Stimulating Hormone Receptor,Seven Transmembrane Helix Receptor,Thyrotropin Receptor-I, HTSHR-I,Thyrotropin Receptor,TSH Receptor,HTSHR-I,TSH-R,Receptors, Thyrotropin,CHNG1
최고 연구 개발 단계Approved
영어 이름Thyroid stimulating hormone receptor
표적 별명TSHR,Thyroid Stimulating Hormone Receptor,LGR3,Thyroid-Stimulating Hormone Receptor,Seven Transmembrane Helix Receptor,Thyrotropin Receptor-I, HTSHR-I,Thyrotropin Receptor,TSH Receptor,HTSHR-I,TSH-R,Receptors, Thyrotropin,CHNG1
시판 약물 수3
임상 약물 수6
최고 연구 개발 단계Approved

TSHR 제품 목록

  • 속성

    Cell (3)Protein (1)

  • 제품 라이브러리

    온라인 (4)

  • Human (4)

  • 태그

    - (4)

  • 마커

    - (3)Unconjugated (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
CHEK-ATF187
Human
HEK293
Human TSHR (Luc) HEK293 Reporter Cell
CHEK-ATP086
Human
HEK293
HEK293/Human TSHR Stable Cell Line
SCCHO-ATP085
Human
CHO
CHO/Human TSHR Stable Cell Line
TSR-H52P3
Human
HEK293
Human TSHR Full Length Protein (VLP)
총 수량4
  • 1

TSHR분자 배경

The protein encoded by this gene is a membrane protein and a major controller of thyroid cell metabolism. The encoded protein is a receptor for thyrothropin and thyrostimulin, and its activity is mediated by adenylate cyclase. Defects in this gene are a cause of several types of hyperthyroidism. Three transcript variants encoding different isoforms have been found for this gene.

TSHR분자 별명

TSHR,TSH-R,LGR3,TSH R

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Anti-thyroid stimulating hormone receptor chimeric antigen receptor T cell therapy (Innovative Cellular Therapeutics)ICTCAT-023Phase 2 ClinicalInnovative Cellular Therapeutics Co LtdThyroid Neoplasms
상세
ZG-001(Zhigen)ZG-001(Zhigen); JH-001Phase 2 ClinicalHunan Warner Pharmaceutical Factory Chiral Medicine Co Ltd, Hunan Warrant Pharmaceutical Co Ltd, Shanghai Zhigen Pharmaceutical Technology Co LtdDepressive Disorder; Depressive Disorder, Major
상세
ICTCAR-051ICTCAR-051Phase 1 ClinicalInnovative Cellular Therapeutics Co LtdSolid tumours; Thyroid Neoplasms
상세
KSP-0914Phase 1 ClinicalKissei Pharmaceutical Co LtdGraves Disease
상세
GensSci098GenSci098; GenSci-098; GensSci-098; GensSci098; GS-098; YB-101Phase 1 ClinicalChangchun GeneScience Pharmaceuticals Co LtdGoiter; Graves Disease; Graves Ophthalmopathy
상세
ICTCAR-TCICTCAR-TCClinicalInnovative Cellular Therapeutics Co LtdThyroid Neoplasms
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Thyrotropin alfarh-TSH; MRrhTSH; rhTSH-MApprovedGenzyme CorpThyrogenUnited StatesThyroid NeoplasmsGenzyme Corp1998-11-30Diagnostic agents; Goiter, Nodular; Thyroid Neoplasms
상세
Recombinant human thyrotropin (Zelgen Biosciences)ApprovedSuzhou Zelgen Biosciences Co Ltd赛诺璟, 泽速宁Mainland ChinaThyroid NeoplasmsSuzhou Zelgen Biopharmaceuticals Co Ltd2026-01-05Thyroid Neoplasms
상세
Recombinant human thyroid stimulating hormone(Smartnuclide)SNA-001; SNA001; KN040; KN-040ApprovedSmartnuclide Biopharma智舒嘉Mainland ChinaThyroid NeoplasmsSmartnuclide Biopharma2024-04-02Thyroid Neoplasms
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호